These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35720930)

  • 1. Correlation Analysis of CML, sRAGE, and esRAGE and the Measure of Atherosclerosis of Coronary Heart Disease.
    Liu W; Ji Y; Zhang W; Fang F; Cai Q; Li Y
    Comput Intell Neurosci; 2022; 2022():8970860. PubMed ID: 35720930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-sectional Analysis of AGE-CML, sRAGE, and esRAGE with Diabetes and Cardiometabolic Risk Factors in a Community-Based Cohort.
    Loomis SJ; Chen Y; Sacks DB; Christenson ES; Christenson RH; Rebholz CM; Selvin E
    Clin Chem; 2017 May; 63(5):980-989. PubMed ID: 28280052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial differences in circulating levels of the soluble receptor for advanced glycation endproducts in middle-aged and older adults.
    Brinkley TE; Leng X; Nicklas BJ; Kritchevsky SB; Ding J; Kitzman DW; Hundley WG
    Metabolism; 2017 May; 70():98-106. PubMed ID: 28403949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial.
    Colhoun HM; Betteridge DJ; Durrington P; Hitman G; Neil A; Livingstone S; Charlton-Menys V; Bao W; Demicco DA; Preston GM; Deshmukh H; Tan K; Fuller JH
    Diabetes; 2011 Sep; 60(9):2379-85. PubMed ID: 21771973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
    Moriya S; Yamazaki M; Murakami H; Maruyama K; Uchiyama S
    J Stroke Cerebrovasc Dis; 2014; 23(10):2540-2546. PubMed ID: 25282185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal reliability of serum soluble and endogenous secretory receptors for advanced glycation end-products (sRAGE and esRAGE) in healthy women.
    Wu F; Afanasyeva Y; Zeleniuch-Jacquotte A; Zhang J; Schmidt AM; Chen Y
    Cancer Causes Control; 2018 Oct; 29(10):901-905. PubMed ID: 30099629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of soluble receptor for advanced glycation end products isoforms and advanced glycation end products in long-living individuals.
    Scavello F; Tedesco CC; Castiglione S; Maciag A; Sangalli E; Veglia F; Spinetti G; Puca AA; Raucci A
    Biomark Med; 2021 Aug; 15(11):785-796. PubMed ID: 34236256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study.
    Brinkley TE; Semba RD; Kritchevsky SB; Houston DK;
    Am J Clin Nutr; 2020 Dec; 112(6):1558-1565. PubMed ID: 33301008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Soluble Receptor for Advanced Glycation End Product and Endogenous Secretory Soluble Receptor for Advanced Glycation End Product Levels and Carotid Atherosclerosis in Diabetes: A Systematic Review and Meta-Analysis.
    Wang X; Wang Q; Wei D; Chang X
    Can J Diabetes; 2021 Oct; 45(7):634-640. PubMed ID: 33773934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD.
    Gopal P; Reynaert NL; Scheijen JL; Schalkwijk CG; Franssen FM; Wouters EF; Rutten EP
    Respir Res; 2014 Feb; 15(1):24. PubMed ID: 24564838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older Men.
    Lamb LS; Alfonso H; Norman PE; Davis TME; Forbes J; Müench G; Irrgang F; Almeida OP; Golledge J; Hankey GJ; Flicker L; Yeap BB
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4224-4231. PubMed ID: 30137355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function.
    Gohda T; Tanimoto M; Moon JY; Gotoh H; Aoki T; Matsumoto M; Shibata T; Ohsawa I; Funabiki K; Tomino Y
    Diabetes Res Clin Pract; 2008 Aug; 81(2):196-201. PubMed ID: 18550199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease.
    Prasad K; Dhar I; Zhou Q; Elmoselhi H; Shoker M; Shoker A
    Mol Cell Biochem; 2016 Dec; 423(1-2):105-114. PubMed ID: 27714575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Endogenous Secretory Receptor for Advanced Glycation End-Products Levels Are Associated With Inflammation and Carotid Atherosclerosis in Prediabetes.
    Di Pino A; Urbano F; Zagami RM; Filippello A; Di Mauro S; Piro S; Purrello F; Rabuazzo AM
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1701-9. PubMed ID: 26885882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGE-RAGE Interaction Does Not Explain the Clinical Improvements after Therapeutic Fasting in Osteoarthritis.
    Drinda S; Franke S; Schmidt S; Stoy K; Lehmann T; Wolf G; Neumann T
    Complement Med Res; 2018; 25(3):167-172. PubMed ID: 29433120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum advanced glycation end-products and receptors as prognostic biomarkers in diabetics undergoing coronary artery stent implantation.
    Shen Y; Pu LJ; Lu L; Zhang Q; Zhang RY; Shen WF
    Can J Cardiol; 2012; 28(6):737-43. PubMed ID: 23073352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women.
    Semba RD; Ferrucci L; Fink JC; Sun K; Beck J; Dalal M; Guralnik JM; Fried LP
    Am J Kidney Dis; 2009 Jan; 53(1):51-8. PubMed ID: 18789567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation.
    Romero R; Espinoza J; Hassan S; Gotsch F; Kusanovic JP; Avila C; Erez O; Edwin S; Schmidt AM
    J Perinat Med; 2008; 36(5):388-98. PubMed ID: 18593373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of EN-RAGE, sRAGE, and its isoforms: cRAGE, esRAGE in obese patients treated by moderate caloric restriction combined with physical activity conducted in hospital condition.
    Kanikowska D; Kanikowska A; Strojny Z; Kawka E; Zawada A; Rutkowski R; Litwinowicz M; Sato M; Grzymisławski M; Bręborowicz A; Witowski J; Korybalska K
    Cytokine; 2024 Aug; 180():156665. PubMed ID: 38823153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The different roles for the advanced glycation end products axis in heart failure and acute coronary syndrome settings.
    Paradela-Dobarro B; Agra RM; Álvarez L; Varela-Román A; García-Acuña JM; González-Juanatey JR; Álvarez E; García-Seara FJ
    Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1050-1060. PubMed ID: 31371263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.